WallStreetZenWallStreetZen

NASDAQ: ELTX
Elicio Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for ELTX

Based on 1 analyst offering 12 month price targets for Elicio Therapeutics Inc

Min Forecast
$13.00+30.78%
Avg Forecast
$13.00+30.78%
Max Forecast
$13.00+30.78%

Should I buy or sell ELTX stock?

Based on 1 analyst offering ratings for Elicio Therapeutics Inc.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although ELTX's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates ELTX as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their ELTX stock forecasts and price targets.

ELTX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-07-17

1 of 1

Forecast return on equity

Is ELTX forecast to generate an efficient return?

Company
N/A
Industry
119.29%
Market
-46.52%

Forecast return on assets

Is ELTX forecast to generate an efficient return on assets?

Company
N/A
Industry
46.9%

ELTX earnings per share forecast

What is ELTX's earnings per share in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$2.69
Avg 2 year Forecast
-$2.47

ELTX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ELTX$9.94$13.00+30.78%Buy
LXEO$4.79$17.17+258.39%Strong Buy
BDTX$2.79$12.00+330.11%Strong Buy
BHST$9.22$14.00+51.89%Buy
ACTU$8.22$20.00+143.31%Buy
View Top Biotech Stocks

Elicio Therapeutics Stock Forecast FAQ

Is Elicio Therapeutics Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: ELTX) stock is to Buy ELTX stock.

Out of 1 analyst, 0 (0%) are recommending ELTX as a Strong Buy, 1 (100%) are recommending ELTX as a Buy, 0 (0%) are recommending ELTX as a Hold, 0 (0%) are recommending ELTX as a Sell, and 0 (0%) are recommending ELTX as a Strong Sell.

If you're new to stock investing, here's how to buy Elicio Therapeutics stock.

What is ELTX's earnings growth forecast for 2025-2026?

(NASDAQ: ELTX) Elicio Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 5.43%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.25%.

Elicio Therapeutics's earnings in 2025 is -$51,280,000.On average, 1 Wall Street analyst forecast ELTX's earnings for 2025 to be -$43,031,865, with the lowest ELTX earnings forecast at -$43,031,865, and the highest ELTX earnings forecast at -$43,031,865.

In 2026, ELTX is forecast to generate -$39,512,531 in earnings, with the lowest earnings forecast at -$39,512,531 and the highest earnings forecast at -$39,512,531.

What is ELTX's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: ELTX) forecast ROE is N/A, which is considered weak.

What is ELTX's Price Target?

According to 1 Wall Street analyst that have issued a 1 year ELTX price target, the average ELTX price target is $13.00, with the highest ELTX stock price forecast at $13.00 and the lowest ELTX stock price forecast at $13.00.

The Wall Street analyst predicted that Elicio Therapeutics's share price could reach $13.00 by Jul 17, 2026. The average Elicio Therapeutics stock price prediction forecasts a potential upside of 30.78% from the current ELTX share price of $9.94.

What is ELTX's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: ELTX) Elicio Therapeutics's current Earnings Per Share (EPS) is -$3.92. On average, analysts forecast that ELTX's EPS will be -$2.69 for 2025, with the lowest EPS forecast at -$2.69, and the highest EPS forecast at -$2.69. In 2026, ELTX's EPS is forecast to hit -$2.47 (min: -$2.47, max: -$2.47).

What is ELTX's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: ELTX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 46.9%.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.